Title:
NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Document Type and Number:
WIPO Patent Application WO/2010/075517
Kind Code:
A3
Abstract:
A purified compound having activity against hepatitis C virus is disclosed.
Inventors:
BAO DONGHUI (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
Application Number:
PCT/US2009/069420
Publication Date:
June 21, 2012
Filing Date:
December 23, 2009
Export Citation:
Assignee:
PHARMASSET INC (US)
BAO DONGHUI (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
BAO DONGHUI (US)
CHANG WOSNUK (US)
NAGARATHNAM DHANAPALAN (US)
SOFIA MICHAEL JOSEPH (US)
International Classes:
C07H19/04; A61K31/7072; A61K31/7076; A61K31/708; A61P31/18; C07H19/20
Domestic Patent References:
WO2008121634A2 | 2008-10-09 | |||
WO2005003147A2 | 2005-01-13 |
Other References:
CAHARD D ET AL: "ARYLOXY PHOSPHORAMIDATE TRIESTERS AS PRO-TIDES", MINI REVIEWS IN MEDICINAL CHEMISTRY, BENTHAM SCIENCE PUBLISHERS, HILVERSUM, NL, vol. 4, no. 4, 1 January 2004 (2004-01-01), pages 371 - 381, XP008076430, ISSN: 1389-5575
MURAKAMI EISUKE ET AL: "The mechanism of action of beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcyti dme involves a second metabolic pathway leading to beta-D-2'-deoxy-2-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 52, no. 2, February 2008 (2008-02-01), pages 458 - 464, XP002674431, ISSN: 0066-4804
MURAKAMI EISUKE ET AL: "The mechanism of action of beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcyti dme involves a second metabolic pathway leading to beta-D-2'-deoxy-2-fluoro-2'-C-methyluridine 5'-triphosphate, a potent inhibitor of the hepatitis C virus RNA-dependent RNA polymerase", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 52, no. 2, February 2008 (2008-02-01), pages 458 - 464, XP002674431, ISSN: 0066-4804
Attorney, Agent or Firm:
KOWALCHYK, Katherine, M. (P.O. Box 2903Minneapolis, MN, US)
Download PDF:
Previous Patent: WO/2010/075516
Next Patent: BRAIN STATE ANALYSIS BASED ON SELECT SEIZURE ONSET CHARACTERISTICS AND CLINICAL MANIFESTATIONS
Next Patent: BRAIN STATE ANALYSIS BASED ON SELECT SEIZURE ONSET CHARACTERISTICS AND CLINICAL MANIFESTATIONS